The global allergy immunotherapies market is expected to grow at a CAGR of 7.21% during the forecast period. Major challenges in the global allergy immunotherapies market include unknown pathogenesis, increased preference for alternative therapies, and trial failures. As per the latest market research report published by Technavio, the global allergy immunotherapies market size will grow by USD 573.9 million during 2019–2023. Get the free sample report below for the detailed information.

Download the free sample report @ http://bit.ly/2PtAMKi

The unknown pathogenesis of various allergies is the major challenge faced by the global allergy immunotherapies market. The unclear cause of allergy results in physicians misdiagnosing the allergan, and as a result, the treatment prescribed is not as effective as it should be and often leads to adverse events. Such instances discourage the patient from opting the treatment, which reduces the drug adoption rate, thereby posing a challenge to market growth.

Furthermore, due to poor diagnosis of the disease, the patient adherence to the treatment is low; as a result, a large number of the patient population drop out before the completion of the treatment. This is expected to hinder the growth of the market significantly. However, despite the challenges, the global allergy immunotherapies market is expected to grow in an accelerating momentum during the forecast period. To know the complete and in-depth analysis and forecast of this market get the complete report by clicking the link below.

Get the Complete Report @ http://bit.ly/35jh9ek